Reply to: “Extended adjuvant temozolomide in newly diagnosed glioblastoma: is more less?”

par Balana, Carmen, Carrato, Cristina, Vaz, Maria Angeles
Publié dans Neuro Oncol (2020)

Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management

par Cirauqui, Beatriz, Morán, Teresa, Estival, Anna, Quiroga, Vanesa, Etxaniz, Olatz, Balana, Carmen, Navarro, Matilde, Villà, Salvador, Ballester, Rosa, Margelí, Mireia
Publié dans Case Rep Oncol (2020)

ATCT-05 OBJECTIVE RESPONSE (OR) TO NEOADJUVANT TREATMENT IN GLIOBLASTOMA AND ITS IMPACT ON OVERALL SURVIVAL (OS). A META-ANALYSIS OF NEOADJUVANT TRIALS OF THE SPANISH GROUP FOR RES...

par Balana, Carmen, Gil Gil, Miguel, Gallego, Oscar, Berrocal, Alfonso, Sepulveda, Juan, Penas, Ramon de las, Herrero, Ana, Reynes, Gaspar, Luque, Raquel
Publié dans Neuro Oncol (2015)

Prolonged survival after bevacizumab rechallenge in glioblastoma patients with previous response to bevacizumab(†)

par Balaña, Carmen, Estival, Anna, Pineda, Estela, Sepúlveda, Juan, Mesía, Carles, del Barco, Sonia, Gil-Gil, Miguel, Hardy, Max, Indacoechea, Alberto, Cardona, Andrés Felipe
Publié dans Neurooncol Pract (2017)

SURG-01 IS UNRESECTED GLIOBLASTOMA TRULY UNRESECTABLE? AN ANALYSIS OF BASAL MRI'S OF PATIENTS WITH UNRESECTED GLIOBLASTOMA INCLUDED IN THE GENOM009 TRIAL AND THE VARIABILITY OF SUR...

par Teixidor, Pilar, Hostalot, Cristina, Villalba, Gloria, Plans, Gerard, Garcia-Armengol, Roser, Garcia, Juan Jose, Estival, Anna, Penas, Ramon de las, Luque, Raquel, Gil-Gil, Miguel, Sepulveda, Juan, Balana, Carmen
Publié dans Neuro Oncol (2015)

Endometrial stromal tumors: immunohistochemical and molecular analysis of potential targets of tyrosine kinase inhibitors

par Sardinha, Ruth, Hernández, Teresa, Fraile, Susana, Tresserra, Francesc, Vidal, August, Gómez, Maria Carmén, Astudillo, Aurora, Hernández, Nieves, Saenz de Santamaría, Javier, Ordi, Jaume, Gonçalves, Luis, Ramos, Rafael, Balañá, Carmen, de Álava, Enrique
Publié 2013

ATIM-49 (LTBK-01). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE(®)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (R...

par Rosenthal, Mark A, Balana, Carmen, van Linde, Myra E, Sayehli, Cyrus, Fiedler, Walter M, Wermke, Martin, Massard, Christophe, Mellinghoff, Ingo K, Khasraw, Mustafa, Ang, Agnes, Rasmussen, Erik, Kast, Johannes, Stienen, Sabine, Cloughesy, Timothy F
Publié dans Neuro Oncol (2019)

ET-12 PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

par Cloughesy, Tim, Finocchiaro, Gaetano, Belda-Iniesta, Cristobel, Recht, Lawrence, Brandes, Alba A, Pineda, Estela, Mikkelsen, Tom, Chinot, Olivier, Balana, Carmen, Macdonald, David, Westphal, Manfred, Hopkins, Kirsten, Weller, Michael, Bruey, Jean-Marie, Liu, Bo, Verret, Wendy
Publié 2014

Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients

par Molina, David, Pérez-Beteta, Julián, Martínez-González, Alicia, Sepúlveda, Juan M., Peralta, Sergi, Gil-Gil, Miguel J., Reynes, Gaspar, Herrero, Ana, De Las Peñas, Ramón, Luque, Raquel, Capellades, Jaume, Balaña, Carmen, Pérez-García, Víctor M.
Publié dans PLoS One (2016)

Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients

par Estival, Anna, Sanz, Carolina, Ramirez, Jose-Luis, Velarde, Jose Maria, Domenech, Marta, Carrato, Cristina, de las Peñas, Ramón, Gil-Gil, Miguel, Sepúlveda, Juan, Armengol, Roser, Cardiel, Isaac, Berrocal, Alfonso, Luque, Raquel, Herrero, Ana, Balana, Carmen
Publié dans Sci Rep (2019)

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

par Cardona, Andrés F., Ruiz-Patiño, Alejandro, Zatarain-Barrón, Zyanya Lucia, Hakim, Fernando, Jiménez, Enrique, Mejía, Juan Armando, Ramón, Juan Fernando, Useche, Nicolás, Bermúdez, Sonia, Pineda, Diego, Cifuentes, Hernando, Rojas, Leonardo, Ricaurte, Luisa, Pino, Luis Eduardo, Balaña, Carmen, Arrieta, Oscar
Publié dans PLoS One (2019)

A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples

par Esteve-Codina, Anna, Arpi, Oriol, Martinez-García, Maria, Pineda, Estela, Mallo, Mar, Gut, Marta, Carrato, Cristina, Rovira, Anna, Lopez, Raquel, Tortosa, Avelina, Dabad, Marc, Del Barco, Sonia, Heath, Simon, Bagué, Silvia, Ribalta, Teresa, Alameda, Francesc, de la Iglesia, Nuria, Balaña, Carmen
Publié dans PLoS One (2017)

Phase II trial of dacomitinib, a pan–human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification

par Sepúlveda-Sánchez, Juan Manuel, Vaz, María Ángeles, Balañá, Carmen, Gil-Gil, Miguel, Reynés, Gaspar, Gallego, Óscar, Martínez-García, María, Vicente, Elena, Quindós, María, Luque, Raquel, Ramos, Ana, Ruano, Yolanda, Pérez-Segura, Pedro, Benavides, Manuel, Sánchez-Gómez, Pilar, Hernández-Laín, Aurelio
Publié dans Neuro Oncol (2017)

Genotyping low-grade gliomas among Hispanics

par Cardona, Andrés Felipe, Rojas, Leonardo, Wills, Beatriz, Behaine, José, Jiménez, Enrique, Hakim, Fernando, Useche, Nicolás, Bermúdez, Sonia, Arrieta, Oscar, Mejía, Juan Armando, Ramón, Juan Fernando, Carranza, Hernán, Vargas, Carlos, Otero, Jorge, González, Diego, Rodríguez, July, Ortiz, León Darío, Cifuentes, Hernando, Balaña, Carmen
Publié dans Neurooncol Pract (2016)

Pseudoprogression as an adverse event of glioblastoma therapy

par Balaña, Carmen, Capellades, Jaume, Pineda, Estela, Estival, Anna, Puig, Josep, Domenech, Sira, Verger, Eugenia, Pujol, Teresa, Martinez‐García, Maria, Oleaga, Laura, Velarde, JoseMaria, Mesia, Carlos, Fuentes, Rafael, Marruecos, Jordi, Del Barco, Sonia, Villà, Salvador, Carrato, Cristina, Gallego, Oscar, Gil‐Gil, Miguel, Craven‐Bartle, Jordi, Alameda, Francesc
Publié dans Cancer Med (2017)

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

par Weller, Michael, van den Bent, Martin, Preusser, Matthias, Le Rhun, Emilie, Tonn, Jörg C., Minniti, Giuseppe, Bendszus, Martin, Balana, Carmen, Chinot, Olivier, Dirven, Linda, French, Pim, Hegi, Monika E., Jakola, Asgeir S., Platten, Michael, Roth, Patrick, Rudà, Roberta, Short, Susan, Smits, Marion, Taphoorn, Martin J. B., von Deimling, Andreas, Westphal, Manfred, Soffietti, Riccardo, Reifenberger, Guido, Wick, Wolfgang
Publié dans Nat Rev Clin Oncol (2020)

A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)

par Balana, Carmen, Vaz, Maria Angeles, Manuel Sepúlveda, Juan, Mesia, Carlos, del Barco, Sonia, Pineda, Estela, Muñoz-Langa, Jose, Estival, Anna, de las Peñas, Ramón, Fuster, Jose, Gironés, Regina, Navarro, Luis Miguel, Gil-Gil, Miguel, Alonso, Miriam, Herrero, Ana, Peralta, Sergio, Olier, Clara, Perez-Segura, Pedro, Covela, Maria, Martinez-García, Maria, Berrocal, Alfonso, Gallego, Oscar, Luque, Raquel, Perez-Martín, Franciso Javier, Esteve, Anna, Munne, Nuria, Domenech, Marta, Villa, Salvador, Sanz, Carolina, Carrato, Cristina
Publié dans Neuro Oncol (2020)

NIMG-66. AI-BASED PROGNOSTIC IMAGING BIOMARKERS FOR PRECISION NEUROONCOLOGY AND THE RESPOND CONSORTIUM

par Davatzikos, Christos, Badve, Chaitra, Kazerooni, Anahita Fathi, Bashyam, Vishnu, Bakas, Spyridon, Colen, Rivka, Mahajan, Abhishek, Balaña, Carmen, Capellades, Jaume, Puig, Josep, Jain, Rajan, Sloan, Andrew E, Marcus, Daniel S, Choi, Yoon Seong, Lee, Seung-Koo, Chang, Jong Hee, Poisson, Laila M, Griffith, Brent, Dicker, Adam P, Flanders, Adam E, Booth, Thomas C, Rathore, Saima, Akbari, Hamed, Sako, Chiharu, Bilello, Michel, Shukla, Gaurav, Brem, Steven, Lustig, Robert, Mohan, Suyash, Nasrallah, MacLean, O’Rourke, Donald M, Bagley, Stephen, Barnholtz-Sloan, Jill S
Publié dans Neuro Oncol (2020)

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma: A randomized phase III Intergroup study by EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033)

par Baumert, Brigitta G., Hegi, Monika E., van den Bent, Martin J., von Deimling, Andreas, Gorlia, Thierry, Hoang-Xuan, Khê, Brandes, Alba A., Kantor, Guy, Taphoorn, Martin J.B., Hassel, Mohamed Ben, Hartmann, Christian, Ryan, Gail, Capper, David, Kros, Johan M., Kurscheid, Sebastian, Wick, Wolfgang, Enting, Roelien, Reni, Michele, Thiessen, Brian, Dhermain, Frederic, Bromberg, Jacoline E., Feuvret, Loic, Reijneveld, Jaap C., Chinot, Olivier, Gijtenbeek, Johanna M. M., Rossiter, John P., Dif, Nicolas, Balana, Carmen, Bravo-Marques, Jose, Clement, Paul M., Marosi, Christine, Tzuk-Shina, Tzahala, Nordal, Robert A., Rees, Jeremy, Lacombe, Denis, Mason, Warren P., Stupp, Roger
Publié dans Lancet Oncol (2016)